Publication date: Jun 20, 2025
Follicular helper T (Tfh) cells are a subset of CD4 T cells that help B cells to produce high-affinity antibodies. Efficient Tfh cell induction by vaccines is critical for protective efficacy against diseases. A Tfh epitope, identified from the SARS-CoV-2 spike protein, has been shown to bind to the corresponding HLA and activates Tfh cells. Here, we assessed the efficacy of a peptide vaccine conjugated with SARS-CoV-2 Tfh epitope against experimental hypertension in a mouse model. The Tfh-angiotensin II (Tfh-Ang II) vaccine activated Tfh and germinal center B cells and induced antibodies against Ang II, thereby suppressing hypertension. However, Ang II-specific autoreactive T cells were not induced. Interestingly, Tfh-Ang II-induced antibody production was enhanced by SARS-CoV-2 spike priming. Moreover, human peripheral blood mononuclear cells from individuals vaccinated with COVID-19 mRNA vaccine were activated by Tfh epitope. Collectively, the SARS-CoV-2 spike-derived universal Tfh epitope may be effective for peptide-based vaccine development.
Open Access PDF
Concepts | Keywords |
---|---|
Cd4 | Immunology |
Efficient | Virology |
Hypertension | |
Model | |
Vaccine |
Semantics
Type | Source | Name |
---|---|---|
disease | IDO | cell |
disease | MESH | hypertension |
drug | DRUGBANK | Angiotensin II |
disease | IDO | blood |
disease | MESH | COVID-19 |